Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Alexander Kaizer to Randomized Controlled Trials as Topic

This is a "connection" page, showing publications Alexander Kaizer has written about Randomized Controlled Trials as Topic.

 
Connection Strength
 
 
 
0.923
 
  1. Kaizer AM, Zhan X, Baron E, Tang RS, Hong DS, Hobbs BP. Master Protocol Design With Hybrid Control for Efficient Early-Phase Trial Consolidation. JCO Precis Oncol. 2025 Aug; 9:e2500507.
    View in: PubMed
    Score: 0.586
  2. Kaizer AM, Wild J, Lindsell CJ, Rice TW, Self WH, Brown S, Thompson BT, Hart KW, Smith C, Pulia MS, Shapiro NI, Ginde AA. Trial of Early Antiviral Therapies during Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19: a summary of the protocol and analysis plan for a decentralized randomized controlled trial. Trials. 2022 Apr 08; 23(1):273.
    View in: PubMed
    Score: 0.113
  3. Zabor EC, Kaizer AM, Hobbs BP. Randomized Controlled Trials. Chest. 2020 07; 158(1S):S79-S87.
    View in: PubMed
    Score: 0.100
  4. Kaizer AM, Koopmeiners JS, Hobbs BP. Bayesian hierarchical modeling based on multisource exchangeability. Biostatistics. 2018 04 01; 19(2):169-184.
    View in: PubMed
    Score: 0.086
  5. Paez R, Khalil TA, Forero Y, Woodhouse P, Antic S, Holmes H, Fremont RD, Brandt W, Chen H, Chen SC, Kaizer A, Shojaee S, Lentz RJ, Deppen SA, BarĂ³n AE, Grogan EL, Maldonado F. Assessing a biomarker platform for stratifying indeterminate pulmonary nodules, protocol for the SPOT IT randomized trial. Trials. 2026 May 12; 27(1).
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)